Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south‐east Nigeria

Health Expectations - Tập 21 Số 1 - Trang 270-278 - 2018
Chinyere Mbachu1,2, Chijioke Okoli3,2, Obinna Onwujekwe3,2, Fabian Enabulele4
1Department of Community Medicine, University of Nigeria Enugu Campus, Enugu, Nigeria
2Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria Enugu Campus, Enugu, Nigeria
3Department of Health Administration and Management College of Medicine, University of Nigeria Enugu Campus, Enugu, Nigeria
4College of Health Sciences, Ebonyi state University, Abakaliki, Nigeria

Tóm tắt

AbstractBackgroundThe current trend of withdrawal of donor support for HIV/AIDS treatment in Nigeria may require that the cost of antiretroviral drugs be borne in part by infected people and their families.ObjectiveThis study was conducted to determine the economic value for free antiretroviral drugs (ARVs) expressed by clients receiving treatment for HIV/AIDS in a tertiary hospital.Study methodThe contingent valuation method was used to elicit the values attached to free ARVs from people living with HIV/AIDS that were receiving care in a public tertiary hospital in south‐east Nigeria. Exit poll using a pre‐tested questionnaire was undertaken with adult clients on treatment. The bidding game technique was used to elicit their willingness to pay (WTP) for ARVs for themselves and members of their households. Ordinary least squares (OLS) multiple regression analysis was used to test the construct validity of elicited WTP amounts.ResultsAbout a third of the respondents were willing to pay for a monthly supply of ARVs for themselves and household members. The mean WTP for monthly supply of ARVs for self was US$15.32 and for household member was US$15.26 (1US$=₦160). OLS regression analysis showed that employment status and higher socio‐economic status were positively associated with higher WTP. OLS showed that age and transport cost per clinic visit were negatively related to WTP. Knowing the risks of not adhering to treatment protocol was positively related to WTP.ConclusionThe respondents positively valued the free ARVs. This calls for greater financial support for the sustainable provision of the treatment service. However, holistic financing mechanisms should be explored to ensure sustained funding in the event of complete withdrawal of donor support.

Từ khóa


Tài liệu tham khảo

World Health Organization, 2013, Overview: HIV/AIDS

Bertozzi S, 2006, Disease Control Priorities in Developing Countries, 331

Nguyen LT, 2014, The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam, ClinicoEcon Outcomes Res, 6, 101

Zhang X, 2012, Factors associated with the household income of persons living with HIV/AIDS in China, Glob J Health Sci, 4, 108, 10.5539/gjhs.v4n3p108

Iya IB, 2012, The effects of HIV/AIDS scourge on production and income among rural households in Adamawa State of Nigeria, Glob J Health Sci, 4, 245

10.1016/S0140-6736(11)60702-2

10.1016/S0140-6736(06)69158-7

10.1111/j.1365-3156.2011.02836.x

10.1002/hpm.2166

National Primary Health Care Development Agency.Report of the expert group on revitalization of primary health care in Nigeria. Abuja Nigeria;2015.

National Agency for the Control of AIDS.Anti retroviral therapy;2013.https://naca.gov.ng/anti-retroviral-therapy/. Accessed May 9 2017.

10.2989/16085906.2013.851718

10.1177/1098214005278752

10.1186/1748-5908-8-15

10.1093/heapro/dah411

10.1016/S0168-8510(02)00039-8

ForeitKG ForeitJR.Willingness to pay surveys for setting prices for reproductive health products and services: a users manual;2004.

World Health Organization.March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach;2014.

Ajali U, 2006, HIV/AIDS: Scientific, Health and Social Aspects

World Health Organization.Summary count profile for HIV/AIDS treatment scale‐up;2005.

World Bank Group, 2016, Poverty and Shared Prosperity, 10.1596/24734

Joint United Nations Programme on HIV/AIDS World Bank Global HIV/AIDS Program.The global economic crisis and HIV prevention and treatment programmes: vulnerabilities and impact: World Health Organization;2009.

10.1007/s10754-016-9193-5

10.1017/S1744133109990016

MitchellRC CarsonRT.Using surveys to value public goods: the contingent valuation method: resources for the future;1989.

10.1108/S0573-8555(1993)220

10.1021/es990728j

10.1093/heapol/czp046

10.1186/1475-9276-9-1

10.2165/00019053-199814050-00001

Pereira MJ, 2015, Estimating the monetary value of relief of tennis elbow: a contingent valuation study of willingness‐to‐pay, Value Health, 18, A654, 10.1016/j.jval.2015.09.2358

10.1046/j.1524-4733.1998.140201.x

10.1016/S0277-9536(96)00154-2

10.3402/gha.v8.28001

Nanyonjo A, 2015, Estimating the cost of referral and willingness to pay for referral to higher‐level health facilities: a case series study from an integrated community case management programme in Uganda, BMC Health Serv Res, 15, 347, 10.1186/s12913-015-1019-5

10.1371/journal.pone.0122760

10.4103/1119-3077.134054

10.1016/j.ijgo.2013.03.024

10.1080/17290376.2004.9724833

10.1046/j.1365-3156.2001.00745.x

10.1002/hec.857

10.1002/hec.4730010405

10.1080/21606544.2016.1199976

10.1016/S0168-8510(99)00010-X

10.1016/S0277-9536(03)00214-4

Onwujekwe O, 2006, Socio‐economic differences in preferences and willingness to pay for different providers of malaria treatment in southeast Nigeria, Am J Trop Med Hyg, 75, 421, 10.4269/ajtmh.2006.75.421

Poder TG, 2014, Willingness to pay for ovulation induction treatment in case of WHO II anovulation: a study using the contingent valuation method, Patient Prefer Adherence, 8, 1337, 10.2147/PPA.S67742

10.1016/S0277-9536(01)00047-8

10.1016/S0277-9536(01)00355-0

Onjukwe OE, 2002, Validity and reliability of the contingent valuation method: a study of willingness to pay for insecticide‐treated nets in Nigeria, PhD thesis, London School of Hygiene & Tropical Medicine

VanVugtM HamersR SchellekensO DeWitTR ReissP.Diabetes and HIV/AIDS in sub‐Saharan Africa: the need for sustainable healthcare systems.Diabetes voice.2007;52:23‐26.

10.1089/dia.2009.0034

Binswanger HP, 2003, Willingness to pay for AIDS treatment: myths and realities, The Lancet, 362, 1152, 10.1016/S0140-6736(03)14473-X

10.1371/journal.pone.0136664

Bravo G, 2016, To what extent do quality‐of‐life ratings influence older adults' preferences regarding future health care and research participation?, Int J Health Prefer Res, 1, 16